Tag: Dihydroergotamine Mesylate Nasal Spray

Cipla gets FDA’s final approval for generic version of Migranal with CGT designation

pharmanewsdaily- May 21, 2020

Cipla has secured final approval for its abbreviated new drug application (ANDA) for Dihydroergotamine Mesylate Nasal Spray 4mg/mL from the US Food and Drug Administration ... Read More